NASDAQ:RXRX   Recursion Pharmaceuticals, Inc.
Expecting a pre run up into the FDA event.

We are having a gap arround 10.

Lots of recent block buys and kind of a middle high short float.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。